Table 3.
Influence of age on engraftment
| <20 years (n = 10) | 20–29 years (n = 10) | 30–39 years (n = 10) | 40–49 years (n = 15) | 50–59 years (n = 16) | ≥60 years (n = 04) | |
| No engraftment | 01 | 01 | 01 | |||
| (01 PBSCT) | (01 BMT) | (01 BMT) | ||||
| Engraftment | 09 | 10 | 10 | 14 | 15 | 04 |
| (07 BMT, 02 PBSCT) | (07 BMT, 03 PBSCT) | (08 BMT, 02 PBSCT) | (08 BMT, 06 PBSCT) | (06 BMT, 09 PBSCT) | (02 BMT, 02 PBSCT) | |
| Neutrophil engraftment | 19.00 | 18.50 | 17.00 | 15.00 | 11.00 | 11.50 |
| (day) | (16.00/29.00)a | (11.00/24.00) | (13.00/19.00) | (11.00/21.00) | (10.00/18.00) | (10.00/18.00) |
| Platelet engraftment | 21.00 | 22.00 | 15.00 | 18.50 | 13.00 | 15.00 |
| (day) | (17.00/25.00) | (13.00/25.00)a | (13.00/21.00) | (11.00/23.00) | (10.00/21.00) | (11.00/20.00) |
| OS (<6 months) | 08/10 (80.00%) | 09/10 (90.00%) | 10/10 (100%) | 14/15 (93.33%) | 14/16 (87.50%) | 4/4 (100%) |
| OS (6–12 months) | 08/10 (80.00%) | 07/10 (70.00%) | 10/10 (100%) | 10/15 (66.67%) | 13/16 (81.25%) | 4/4 (100%) |
OS: overall survival; Neutrophil and platelet engraftment were expressed as median (lower/upper quartile).
a
Significantly different from 50–59 years old.